Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling
出版年份 2022 全文链接
标题
Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling
作者
关键词
NAFLD, Liensinine (LIEN), Lipid deposition, Oxidative stress and inflammation, TAK1/AMPK
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 104, Issue -, Pages 108306
出版商
Elsevier BV
发表日期
2022-01-07
DOI
10.1016/j.intimp.2021.108306
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liensinine Prevents Vascular Inflammation by Attenuating Inflammatory Mediators and Modulating VSMC Function
- (2021) Moon Young Jun et al. Applied Sciences-Basel
- Nrf2 deficiency aggravates PM2.5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder
- (2020) Chenxu Ge et al. Aging-US
- Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
- (2020) Ze Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Functional loss of inactive rhomboid-like protein 2 mitigates obesity by suppressing pro-inflammatory macrophage activation-triggered adipose inflammation
- (2020) Minxuan Xu et al. Molecular Metabolism
- Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1
- (2020) Liping Wu et al. FREE RADICAL BIOLOGY AND MEDICINE
- iRhom2 promotes hepatic steatosis by activating MAP3K7‐dependent pathway
- (2020) Minxuan Xu et al. HEPATOLOGY
- Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission
- (2020) Xinyue Liang et al. PHARMACOLOGICAL RESEARCH
- Activation of the AMP-related kinase (AMPK) induces renal vasodilatation and downregulates Nox-derived reactive oxygen species (ROS) generation
- (2020) Claudia Rodríguez et al. Redox Biology
- SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway
- (2020) Yi Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Metformin alleviates lead-induced mitochondrial fragmentation via AMPK/Nrf2 activation in SH-SY5Y cells
- (2020) Luoyao Yang et al. Redox Biology
- Nrf2 mitigates prolonged PM2.5 exposure-triggered liver inflammation by positively regulating SIKE activity: Protection by Juglanin
- (2020) Chenxu Ge et al. Redox Biology
- Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
- (2020) Oren Rom et al. Science Translational Medicine
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Activation of TGF-β-activated kinase 1 (TAK1) restricts Salmonella Typhimurium growth by inducing AMPK activation and autophagy
- (2018) Wei Liu et al. Cell Death & Disease
- Liver X receptors regulate hepatic F4/80+CD11b+ Kupffer cells/macrophages and innate immune responses in mice
- (2018) Kaori Endo-Umeda et al. Scientific Reports
- Is TAK1 a Direct Upstream Kinase of AMPK?
- (2018) Dietbert Neumann INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liensinine perchlorate inhibits colorectal cancer tumorigenesis by inducing mitochondrial dysfunction and apoptosis
- (2018) Yang Wang et al. Food & Function
- Inflammatory mechanisms linking obesity and metabolic disease
- (2017) Alan R. Saltiel et al. JOURNAL OF CLINICAL INVESTIGATION
- The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
- (2017) Peng Zhang et al. NATURE MEDICINE
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of nonalcoholic fatty liver disease: role of AMPK
- (2016) Brennan K. Smith et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease
- (2016) Steven E. Trasino et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway
- (2016) Guido Carpino et al. PLoS One
- A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission
- (2015) Jing Zhou et al. Autophagy
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Protective effect of liensinine on periodontitis through its antioxidant effect in mice
- (2015) Liang Pang et al. Journal of the Korean Society for Applied Biological Chemistry
- Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway
- (2015) Li-Li Qu et al. PHYTOTHERAPY RESEARCH
- TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
- (2014) Sayaka Inokuchi-Shimizu et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of Nrf2 in chronic liver disease
- (2014) Wei Tang WORLD JOURNAL OF GASTROENTEROLOGY
- Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease
- (2013) Lake Li et al. FOOD AND CHEMICAL TOXICOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Cell type-specific function of TAK1 in innate immune signaling
- (2013) Adebusola A. Ajibade et al. TRENDS IN IMMUNOLOGY
- Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems
- (2012) Ping Song et al. FREE RADICAL BIOLOGY AND MEDICINE
- TAK1, more than just innate immunity
- (2012) Liang Dai et al. IUBMB LIFE
- Inflammatory Mechanisms in Obesity
- (2011) Margaret F. Gregor et al. Annual Review of Immunology
- Macrophages, Inflammation, and Insulin Resistance
- (2010) Jerrold M. Olefsky et al. Annual Review of Physiology
- Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-κB and JNK/p38 MAPK pathways
- (2010) Ke-Wu Zeng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet☆
- (2010) Yu-Kun Jennifer Zhang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells
- (2009) Griselda Herrero-Martín et al. EMBO JOURNAL
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
- (2009) Emmanuel Mas et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started